Today: 14 May 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Honeywell (HON) Stock Today: Price, Earnings, Breakup Plan and 2026 Forecast (December 1, 2025)

Honeywell (HON) Stock Today: Price, Earnings, Breakup Plan and 2026 Forecast (December 1, 2025)

Honeywell closed at $190.22 on December 1, down 1% for the day and about 16% below its 52-week high. The company recently beat Q3 earnings estimates, raised full-year guidance, and completed the Solstice Advanced Materials spin-off. Bank of America double-downgraded the stock to Underperform, while most analysts still rate it a Buy. Honeywell plans to split into Aerospace and Automation firms by 2026.
1 December 2025
···
Wells Fargo (WFC) Stock on December 1, 2025: Price, Dividend, Lawsuit Settlement and 2025–2030 Forecast

Wells Fargo (WFC) Stock on December 1, 2025: Price, Dividend, Lawsuit Settlement and 2025–2030 Forecast

Wells Fargo shares closed at $85.4 on December 1, 2025, down just over half a percent, after hitting a record $88.54 in November. The bank reported Q3 net income of $5.6 billion, up from $5.1 billion a year earlier, and raised its medium-term ROTCE target to 17–18% after the Fed lifted its asset cap. Market cap stands near $270 billion. December 1 marked both a dividend payout and an $85 million class-action settlement.
1 December 2025
··
Verizon Communications Inc. (VZ) Stock in December 2025: Earnings, 7% Dividend Yield and Frontier Deal Update

Verizon Communications Inc. (VZ) Stock in December 2025: Earnings, 7% Dividend Yield and Frontier Deal Update

Verizon closed December 1, 2025, at $40–41 per share, with a $173 billion market cap and a 6.7–6.8% dividend yield. Third-quarter revenue reached $33.8 billion, up 1.5% year-over-year, while adjusted EPS was $1.21. Wireless service revenue rose to $21.0 billion. Total unsecured debt fell to $119.7 billion from $126.4 billion a year earlier.
1 December 2025
···
Union Pacific (UNP) Stock on December 1, 2025: Merger Risks, Dividend Strength and Wall Street’s 2026 Price Targets

Union Pacific (UNP) Stock on December 1, 2025: Merger Risks, Dividend Strength and Wall Street’s 2026 Price Targets

Union Pacific closed at $231.36 on December 1, 2025, valuing the company at $137 billion, with shares trading between $204.66 and $256.84 over the past year. Q3 adjusted EPS rose 12% to $3.08, net income climbed 9% to $1.8 billion, and operating revenue reached $6.24 billion. The company faces elevated regulatory and merger risk as it pursues an $85 billion Norfolk Southern deal.
1 December 2025
····
Texas Instruments (TXN) Stock on December 1, 2025: Earnings Hangover, $60 Billion Fab Bet and What Wall Street Expects Next

Texas Instruments (TXN) Stock on December 1, 2025: Earnings Hangover, $60 Billion Fab Bet and What Wall Street Expects Next

Texas Instruments shares traded near $168 on December 1, 2025, valuing the company at about $152 billion, down roughly 10% year-to-date and 16% over 12 months. Q3 revenue rose 14% to $4.74 billion, beating estimates, but the stock remains below its 52-week high as investors weigh heavy spending and a softer earnings outlook.
1 December 2025
··
Chevron (CVX) Stock Today: HSBC Upgrade, CPC Drone Attack Fallout and 2030 Cash‑Flow Roadmap

Chevron (CVX) Stock Today: HSBC Upgrade, CPC Drone Attack Fallout and 2030 Cash‑Flow Roadmap

Chevron shares traded at $152–153 on Monday after HSBC upgraded the stock to Buy and raised its price target to $169. The move follows a drone attack on a key export terminal and renewed focus on Chevron’s 2030 free-cash-flow plan. CVX yields 4.4–4.6% with a $1.71 quarterly dividend, and has returned 10.6% year to date. Market cap stands near $300 billion.
1 December 2025
··
AbbVie (ABBV) Stock in December 2025: Atogepant Breakthrough, Q3 Beat and 2026 Outlook After Medicare Price Cuts

AbbVie (ABBV) Stock in December 2025: Atogepant Breakthrough, Q3 Beat and 2026 Outlook After Medicare Price Cuts

AbbVie shares closed near $225 on December 1, 2025, valuing the company at about $400 billion. Q3 net revenue rose 9.1% to $15.78 billion, with adjusted EPS of $1.86 topping estimates. The company raised its 2025 profit forecast and approved a 5.5% dividend increase. Immunology sales climbed, while Humira revenue dropped below $1 billion.
1 December 2025
····
Exxon Mobil (XOM) Stock Today: UBS Sets $145 Target as Guyana Output Surges and Dividend Yield Nears 3.5%

Exxon Mobil (XOM) Stock Today: UBS Sets $145 Target as Guyana Output Surges and Dividend Yield Nears 3.5%

Exxon Mobil traded near $117 on December 1, 2025, close to its 52-week high, with a market cap of about $492 billion. UBS issued a “Buy” rating and a $145 target, citing strong production in Guyana and the Permian. The company raised its quarterly dividend to $1.03 per share, yielding 3.5%. Oil prices remain subdued, with Brent at $63 and OPEC+ maintaining current output cuts.
1 December 2025
···
Analog Devices (ADI) Stock on December 1, 2025: Earnings Momentum, Insider Moves and 2026 Forecasts

Analog Devices (ADI) Stock on December 1, 2025: Earnings Momentum, Insider Moves and 2026 Forecasts

Analog Devices closed December 1, 2025 at $266.51, near record highs after a post-earnings surge and analyst upgrades. Q4 revenue rose 26% to $3.08 billion, beating forecasts, with adjusted EPS up 35% to $2.26. Several valuation models now flag the stock as expensive, and technical signals show overbought conditions. Shares are up 26% year-to-date but have trailed the broader tech sector’s gains.
1 December 2025
··
Silver Price Hits Record Above $58 as 2025 Rally Goes Parabolic – What Comes Next in 2026–2027?

Silver Price Hits Record Above $58 as 2025 Rally Goes Parabolic – What Comes Next in 2026–2027?

Silver surged to record highs above $58 per ounce on December 1, 2025, more than doubling year-to-date. Spot prices touched $58.83 and futures briefly topped $59, driven by supply deficits, strong industrial demand, and a weaker dollar. The rally has outpaced gold, with analysts divided over whether prices can hold above $60. Trading disruptions and shrinking inventories have added to volatility.
1 December 2025
·
Beyond Meat Hit With $38.9M Vegadelphia Verdict as BYND Stock Lures Bullish Options Traders

Beyond Meat Hit With $38.9M Vegadelphia Verdict as BYND Stock Lures Bullish Options Traders

Beyond Meat faces a $38.9 million trademark verdict after a federal jury found it infringed Vegadelphia Foods’ slogan. The company, now trading near $1 per share, is also under new securities-fraud investigations and reported deepening losses and impairments. Beyond Meat says it will appeal the verdict. Cash holdings stood at $131 million against $1.2 billion in debt as of late September.
1 December 2025
Nike (NKE) Stock on December 1, 2025: Ex‑Dividend Drop, Wall Street Targets, and 2026 Outlook

Nike (NKE) Stock on December 1, 2025: Ex‑Dividend Drop, Wall Street Targets, and 2026 Outlook

Nike shares traded around $65.70 on December 1, 2025, up 1–2% intraday despite going ex-dividend for a new $0.41 quarterly payout. The stock is down about 17% over the past year and roughly 50% over five years. Analysts’ average 12-month price target sits in the low-to-mid $80s, implying 25–30% upside from current levels. Nike’s dividend yield now stands near 2.5%.
1 December 2025
···
Exact Sciences (EXAS) Stock: Abbott’s $23 Billion Deal, Q3 Earnings Beat and What Investors Should Watch Now

Exact Sciences (EXAS) Stock: Abbott’s $23 Billion Deal, Q3 Earnings Beat and What Investors Should Watch Now

Abbott Laboratories has agreed to acquire Exact Sciences for $105 per share in cash, valuing the deal at up to $23 billion including debt. Exact Sciences stock traded at $101.27 mid-day December 1, near its all-time high after a 56% surge in November. The transaction is expected to close in Q2 2026, pending approvals. The offer represents a 22% premium to Exact’s pre-deal price.
1 December 2025
··
Q32 Bio (QTTB) Stock Explodes After $592 Million Akebia Deal – Latest News, Analyst Targets and 2027 Outlook

Q32 Bio (QTTB) Stock Explodes After $592 Million Akebia Deal – Latest News, Analyst Targets and 2027 Outlook

Q32 Bio shares jumped as much as 170% intraday on December 1 after announcing the sale of its Phase 2 drug ADX-097 to Akebia Therapeutics for $12 million upfront and up to $592 million in milestones. Trading volume soared into the hundreds of millions. The company will now focus on its lead autoimmune drug, bempikibart, for alopecia areata.
1 December 2025
···
1 … 775 776 777 778 779 … 811

Stock Market Today

  • ASX opens slightly down as Australian dollar nears four-year high amid federal budget focus
    May 14, 2026, 1:09 PM EDT. The ASX opened marginally lower, with the S&P/ASX 200 down 0.1% to 8,623 points as investors absorbed the federal budget. The Australian dollar remains notably strong, holding above 72 US cents and nearing a four-year high last seen in April 2022. Analysts attribute the currency's resilience to Australia's hawkish central bank, robust demand for LNG and industrial metals, and solid equity markets. Forecasts suggest further gains, with some predicting a rise to 75-76 US cents by 2026. The US Senate confirmation of Kevin Warsh for Federal Reserve chair, seen as favoring softer US interest rates, also boosted the AUD. Global markets showed mixed moves with the S&P 500 up 0.59% and oil prices steady. The ASX 200 has fallen 2.67% over five days but remains flat year-to-date.

Latest articles

MARA Holdings Stock Jumps As $1.5 Billion Bitcoin Sale Puts AI Bet In Focus

MARA Holdings Stock Jumps As $1.5 Billion Bitcoin Sale Puts AI Bet In Focus

14 May 2026
MARA shares rose 5.8% to $13.49 in midday Nasdaq trading Thursday after the company sold 20,880 bitcoin in Q1, cutting holdings to 35,303 BTC. Quarterly revenue fell 18% to $174.6 million, with net loss widening to $1.26 billion on lower bitcoin prices. MARA plans a $1.5 billion acquisition of Long Ridge Energy & Power to expand into AI and high-performance computing.
Broadcom Stock Hits Record Before June 3 Earnings as Wall Street Bets AI Has More Room to Run

Broadcom Stock Hits Record Before June 3 Earnings as Wall Street Bets AI Has More Room to Run

14 May 2026
Broadcom shares rose 4.6% to $436.03 midday Thursday, hitting a record after analyst price target hikes and ahead of its June 3 earnings report. The company previously guided for $22 billion in fiscal Q2 revenue, up 47% year-over-year, with AI chip sales driving growth. Market value topped $2.1 trillion. Broadcom’s partnership with OpenAI targets custom AI accelerator deployments starting in late 2026.
Nu Holdings Stock Faces a Big Test Tonight as Nubank Reports Q1 Results

Nu Holdings Stock Faces a Big Test Tonight as Nubank Reports Q1 Results

14 May 2026
Nu Holdings will report first-quarter results after the New York market close, with a call at 6 p.m. ET. Analysts expect earnings of $0.20 per share and revenue near $5.06 billion. NU shares rose 0.9% to $12.94 in midday trading. Nubank ended 2025 with 131 million customers, up 15% from a year earlier.
SoFi’s PrimaryBid Deal Puts It Back in the IPO Race as Rate-Cut Hopes Fade

SoFi’s PrimaryBid Deal Puts It Back in the IPO Race as Rate-Cut Hopes Fade

14 May 2026
SoFi has acquired technology from UK-based PrimaryBid to expand retail investor access to IPOs and capital raises. The deal comes amid renewed U.S. IPO activity, including Cerebras’ $5.55 billion offering. Financial terms were not disclosed. SoFi shares rose to $15.76 midday, valuing the company at $21.7 billion.
Go toTop